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Mycobacterium tuberculosis, the agent of human tuberculosis has developed different virulence 
mechanisms and virulence-associated tools during its evolution to survive and multiply inside the 
host. Based on previous reports and by analogy with other bacteria, phospholipases C (PLC) of 
M. tuberculosis were thought to be among these tools. To get deeper insights into the function of 
PLCs, we investigated their putative involvement in the intracellular lifestyle of M. tuberculosis, with 
emphasis on phagosomal rupture and virulence, thereby re-visiting a research theme of longstanding 
interest. Through the construction and use of an M. tuberculosis H37Rv PLC-null mutant (ΔPLC) and 
control strains, we found that PLCs of M. tuberculosis were not required for induction of phagosomal 
rupture and only showed marginal, if any, impact on virulence of M. tuberculosis in the cellular and 
mouse infection models used in this study. In contrast, we found that PLC-encoding genes were 
strongly upregulated under phosphate starvation and that PLC-proficient M. tuberculosis strains 
survived better than ΔPLC mutants under conditions where phosphatidylcholine served as sole 
phosphate source, opening new perspectives for studies on the role of PLCs in the lifecycle of M. 
tuberculosis.
Most of the ~130 mycobacterial species1 are harmless to humans, whereas a few pose major threats to 
human health and life. Among the latter is Mycobacterium tuberculosis, the etiological agent of tuber-
culosis, which transmits efficiently among humans and globally accounts for 9 million new tuberculosis 
cases and 1.5 million deaths each year2. Many factors have been reported that contribute to the outstand-
ing efficacy of M. tuberculosis to infect its host and circumvent eradication by the immune system3,4. 
Genome-based studies and advanced gene knock-out techniques have been instrumental for the iden-
tification of numerous virulence factors of M. tuberculosis that seem to be important for its lifestyle as 
key pathogen5,6. Comparative sequence analyses were also important for finding polymorphisms useful 
for molecular epidemiology7 and evolutionary studies8. Among the different approaches, genomic com-
parison of environmental, saprophytic mycobacteria with clinically relevant mycobacteria may provide 
important information.
One of the potential differences emerging from the comparison of non-pathogenic with pathogenic 
mycobacterial species is the presence of genes encoding phospholipase C (PLC) in the latter. For example, 
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Mycobacterium abscessus, which represents an exceptional, emerging pathogen within the large group of 
otherwise mostly harmless fast-growing mycobacteria9–12, encodes a PLC involved in the intracellular 
survival of M. abscessus in amoebae13. Moreover, PLC-encoding genes are also present in several species 
of the slow-growing mycobacteria, which constitute a subgroup in the 16 S rDNA-based mycobacterial 
phylogeny14 and harbour the great majority of mycobacterial pathogens. Only few studies have addressed 
the impact of PLC on virulence of these pathogens. The most well known of these studies targeted PLCs 
of a clinical M. tuberculosis strain (MT103) and reported that PLC-knock-out mutants of this strain were 
attenuated at later stages of infection15. Together with reported cytotoxic effects of PLC16, these results 
were taken up by numerous review articles on mycobacterial pathogenicity5,17–19, leading to the wide-
spread supposition that PLCs were important virulence factors of M. tuberculosis.
In the present study, we thus sought to gain deeper insights into the molecular mechanisms by which 
PLCs might contribute to virulence of M. tuberculosis. PLCs from selected species of other bacterial 
genera, such as Listeria monocytogenes or Clostridium perfringens, are known to play a significant role 
in helping the bacteria to escape from phagosomal containment inside host cells by acting together with 
pore-forming proteins such as listeriolysin or perfringolysin20–22.
M. tuberculosis was reported to produce membrane-damaging proteins associated with the ESX-1 
secretion system, which are required for induction of phagosomal rupture and bacterial access to the 
cytosolic compartment of infected phagocytic cells4, However, it remains unknown if other bacterial 
factors, as for example PLCs, might also contribute to the M. tuberculosis-mediated disruption of the 
phagosomal membrane.
The first main objective of our study was thus to investigate whether the biological activities of ESX-1 
and mycobacterial PLCs were linked. For this purpose, we constructed a PLC-deletion mutant in the M. 
tuberculosis H37Rv genetic background, and subjected it to dedicated cell-biological analyses in com-
parison with the wild-type (WT) M. tuberculosis H37Rv strain. To evaluate whether the PLC-deletion 
mutants had the ability to induce phagosomal rupture in host-macrophages, we used a recently devel-
oped fluorescence resonance energy transfer (FRET)-based method23,24. Results from the phagosomal 
rupture assay together with virulence tests in cellular and small animal infection models allowed us to 
revisit the role of PLCs of M. tuberculosis in the infection process, which to our surprise was found to 
be only marginal. These results open new perspectives for future research to elucidate the biological role 
of PLCs in M. tuberculosis and related slow-growing mycobacteria.
Results
Genome analysis and deletion of the plcABC operon in an M. tuberculosis H37Rv genetic 
background. Analysis of M. tuberculosis genome data from public databases shows that most M. 
tuberculosis strains harbour four PLC encoding genes. These genes, named plcA, plcB, plcC and plcD are 
located at two different genomic loci in M. tuberculosis, with plcA-B-C organised as an operon (rv2351c-
rv2350c-rv2349c) at genome coordinates 2632–2627 kb (reverse strand) of strain H37Rv, and plcD, rep-
resented as a single gene (rv1755c), located about 640 kb upstream of plcA-C25. It is also known that 
PLC encoding genes are preferred integration sites (or hotspots) for the IS6110 insertion element, which 
may lead to the presence of two insertion elements in close proximity, favouring homologous recombi-
nation between the adjacent IS6110 elements and deletion of the intervening sequences26–28. The widely 
used reference strain M. tuberculosis H37Rv shows such IS6110-mediated truncation of the plcD gene26. 
However, despite plcD inactivation, M. tuberculosis H37Rv retains a fully virulent phenotype in mice29. 
We thus chose the H37Rv strain to construct a null PLC mutant, taking in consideration that truncation 
of plcD facilitated the construction of the PLC complete knock-out strain, as only the PlcA-B-C operon 
had to be deleted.
The M. tuberculosis H37Rv PLC null mutant (H37RvΔ PLC) was constructed by using a previously 
described recombineering-based approach30. The different construction steps included the generation 
by 3-step-PCR31 of a linear DNA fragment containing an apramycin resistance cassette embedded in 
the flanking regions of the plcABC cluster (Fig. 1A), which was genetically transformed into the H37Rv 
strain. Selection of an appropriate clone that showed replacement of the plcABC cluster with the apra-
mycin cassette was assessed by PCR and then confirmed by Southern blotting analysis (Fig.  1B,C). In 
addition, a H37RvΔ PLC::plcABC complemented strain was obtained by integrating the plcABC gene 
cluster into the genome of H37RvΔ PLC using the plasmid pPlcABC. This pYUB412-based vector32 
contains the plcABC operon expressed under the control of its natural promoter.
As controls for selected experiments, we also included the previously described Myc2509Δ PLC 
mutant strain15, here referred to as MT103Δ PLC, and the isogenic MT103 parental M. tuberculosis strain.
Evaluation of phospholipase C activity in mutant and WT M. tuberculosis strains. In a first 
step, we used a spectrophotometric assay to determine the PLC activity of whole-cell extracts from 
WT M. tuberculosis strains and the two PLC-deletion mutants. This assay is based on the detection of 
the hydrolysis of colourless p-nitrophenylphosphorylcholine (p-NPPC) to p-nitrophenol, which absorbs 
light at 410 nm and is yellow. As shown in Fig. 2, the PLC activity was decreased in H37RvΔ PLC com-
pared to the corresponding WT strain. However, a lower PLC activity was detected in M. tuberculosis 
H37Rv strain relative to the MT103 strain, which might be linked to the truncation of the fourth plc 
gene (plcD) in M. tuberculosis H37Rv. Complementation of M. tuberculosis H37RvΔ PLC with plasmid 
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pPlcABC restored PLC activity to the level of the H37Rv WT M. tuberculosis strain. As expected, the 
plcABC-unrelated M. tuberculosis H37Rv mutant ∆ESX1, which is lacking a functional ESX-1 secretion 
system due to the deletion of the region of difference RD123,24,33, showed a phospholipase C activity very 
similar to the H37Rv WT strain (Fig.  2A,B). Taken together, these results confirmed the loss of PCL 
activity in the H37RvΔ PLC mutant.
Phospholipase C is not involved in M. tuberculosis-induced phagosomal rupture. According 
to host-pathogen interaction data reported from a range of bacterial pathogens, phospholipase C activ-
ity is often required for egress of bacteria from phagosomal containment and cytosolic access20–22. We 
thus investigated the ability of PLC mutants H37RvΔ PLC and MT103Δ PLC and WT strains to access 
the cytosol during infection of THP-1 human macrophage-like cells, by using a recent flow-cytometric 
phagosomal rupture screening method23. Briefly, this sensitive assay relies on the change in the emission 
spectrum of the cephalosporin-like FRET substrate CCF-4 upon cleavage by β -lactamases34,35, which 
serves as a readout for the detection of contact between β -lactamase-producing M. tuberculosis and the 
FRET substrate in different environments, including the host cytosol. As CCF-4 cannot enter an intact 
vacuole, the assay assesses whether cytosolic contact of M. tuberculosis occurs in the host cell during 
infection. Differentiated THP-1 cells were infected with the various M. tuberculosis strains at an MOI 
of 1:2, and the CCF-4 emission spectrum of cells was monitored over a three-day period. Both the WT 
and the Δ PLC-deletion M. tuberculosis strains were able to induce a switch in the emission spectrum 
from ~535 nm to ~450 nm, indicating that they were gaining access to the cytosol of the infected THP-1 
cells (Fig. 3). In contrast, the attenuated Δ ESX-1 (Δ RD1) M. tuberculosis strain, which is impaired in 
inducing phagosomal rupture in host cells23,24 and was included in the analysis as a negative control, was 
Figure 1. Construction of M. tuberculosis H37RvplcABC KO (H37RvΔPLC). (A) Schematic 
representation of genomic organization of plc genes in M. tuberculosis H37Rv wild type and H37RvΔ PLC 
strains ; (B) AvrII restriction fragment profiles of M. tuberculosis WT and KO strains separated by agarose 
gel electrophoresis; (C) Pattern obtained from genomic DNAs digested with AvrII and hybridized with a 
probe specific for the plcC downstream region; Lanes: 1 (second lane from left), negative control (pYUB412 
vector); 2, positive control pYUB412::plcABC; 3 and 4, M. tuberculosis H37Rv WT, 5 and 6, M. tuberculosis 
H37RvΔplcABC; 7, M, Smart Ladder (Eurobio).
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unable to induce a FRET inhibition, thereby validating the assay (Fig. 3, Supplementary Figure 1). From 
these results we concluded that PLC of M. tuberculosis was not required for inducing phagosomal rupture 
in THP-1 cells, neither in the H37Rv-, nor in the MT103 genetic backgrounds.
Virulence of M. tuberculosis H37RvΔPLC in the THP-1 infection model. As phagosomal rup-
ture in M. tuberculosis is often linked to virulence36, we evaluated the survival and/or growth of the WT 
and Δ PLC-mutant M. tuberculosis strains in THP-1 cells. WT and mutant M. tuberculosis strains were 
used to infect THP-1 cells at an MOI of 1:20 (1 bacterium per ~ 20 cells), and the number of intracellular 
bacteria was determined immediately after phagocytosis (day 0) and 3, 5 and 7 days post infection. As 
shown in Fig. 4, the H37RvΔ PLC mutant and the corresponding WT strain showed similar intracellular 
growth kinetics, resulting in a 1.5-Log increase in CFU number over a 7-day period. Consistent with 
previous observations from Raynaud and colleagues15, no differences were observed in the intracellu-
lar growth abilities of MT103Δ PLC and its isogenic parental strain. In contrast, the Δ ESX-1 (Δ RD1) 
M. tuberculosis strain, showed attenuated growth relative to WT and Δ PLC strains (Fig. 4). These results 
indicate that PLCs, in contrast to the ESX-1 proteins, are not essential for M. tuberculosis intracellular 
survival and optimal growth in host macrophages.
Virulence of M. tuberculosis in mouse infection models. To further test whether PLC inactivation 
might result in a potential defect in in vivo growth ability that might not be detectable in macrophages 
cell lines, we evaluated the virulence properties of the H37RvΔ PLC and WT strains in different mouse 
infection models.
Given the previously established suitability of the SCID (severe combined immune deficient) mouse 
infection model for distinguishing attenuated Δ ESX-1 (Δ RD1) and virulent WT M. tuberculosis 
strains33,37,38, the potential impact of PLC-inactivation on virulence of M. tuberculosis was first assessed 
Figure 2. Phospholipase C enzymatic assay. This assay is based on the detection of the hydrolysis of 
p-nitrophenylphosphorylcholine (p-NPPC) to p-nitrophenol. While the substrate, p-NPPC, is colourless, 
the product p-nitrophenol due to its ability to absorb light at 410 nm, is yellow. About 500 μ g of total 
protein were used in the assay and measurements were performed in triplicates. (A) Crude extracts of 4 
day-old cultures from different M. tuberculosis strains were incubated with 5 mmol.l−1 of p-nitrophenol 
phosphorylcholine; (B) Measurement of phospholipase activity of different M. tuberculosis strains over 3 
timepoints. Measurements were performed in duplicates.
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by testing the in vivo growth characteristics of Δ PLC and WT M. tuberculosis strains in SCID mice. 
Both the H37Rv Δ PLC mutant and the WT strain displayed an indistinguishable, high bacterial load in 
lungs and spleen of infected mice (Fig. 5A,B). This was also confirmed by visual inspection of the organs, 
which showed typical signs of massive infection (Supplementary Figure 2). Similarly, the MT103Δ PLC 
Figure 3. Phagosomal rupture by M. tuberculosis mutants. Capacity of different M. tuberculosis strains 
and mutants to induce phagosomal rupture inTHP-1 cells, monitored by CCF-4 staining and flow cytometric 
analysis. Non infected (gray), infected (MOI = 1:10) with different strains of M. tuberculosis (purple) using 
a recently developed approach23. Results shown are representative of 2 independent experiments. The shift 
towards blue emission (447 nm) of CCF-4 is due to the inhibition of FRET and is proportional to the 
mycobacteria-induced phagosomal rupture/cytosolic access.
Figure 4. Growth kinetics of M. tuberculosis strains in THP-1 derived macrophages. Number of colony 
forming units (CFU) obtained at different time points after infection. MOI was 1:20 (bacteria/cells). The 
figures show the means and the standard deviations obtained in 3 independent experiments.
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and WT strains both showed comparable, intense in vivo growth in SCID mice, as indicated by the 
presence of ~108 CFU in the organs after 3 weeks of infection, although it should be mentioned that for 
this latter strain couple, the CFU numbers determined for day 1 were somewhat higher for the Δ PLC 
mutant in comparison with the WT strain (Fig. 5A,B).
To determine whether the findings obtained in the SCID mouse model were also relevant in immu-
nocompetent mice, virulence studies with the H37Rv and MT103 Δ PLC and WT strain-pairs were also 
performed in an aerosol infection model of C57BL/6 mice, where the bacterial load in target organs 
was determined after 6 weeks of infection. As shown in Fig.  5C and Supplementary Figure 3, we did 
not observe a significant difference between WT and Δ PLC mutants in their in vivo growth properties. 
These findings, which are in overall agreement with results from the phagosomal rupture screen and 
the THP-1 infection assay, suggest that PLCs from M. tuberculosis might not represent very obvious 
virulence factors of M. tuberculosis.
Expression of plcABC genes seems to linked to phosphate concentration. Previous studies on 
PLCs of P. aeruginosa have shown that induction of PLC expression was phosphate regulated, suggesting 
Figure 5. Virulence evaluation of M. tuberculosis strains in different mouse infection models. Number of 
colony forming units (CFU) 3 weeks days after intravenous infection with M. tuberculosis WT and mutant 
strains in (A) lungs; and (B) spleens of SCID mice. (C) Panel C shows the in vitro growth characteristics of 
the same panel of strains as above, in C57BL/6 mice 6 weeks after infection. Results shown are representative 
of 2 independent experiments.
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a putative role of PLCs for retrieval of phosphate from the environment20,39. To investigate whether 
PLCs of M. tuberculosis might present similar features, we established an in vitro growth model under 
phosphate-limiting conditions (Supplementary Figure 4). For monitoring promoter activities, a recombi-
nant Δ PLC M. tuberculosis H37Rv strain expressing a translational 5′-plcA-egfp fusion under the natural 
plcABC promoter was constructed and named H37RvΔ PLC::plcA-egfp. Results obtained from growth 
experiments with this strain showed that during the first 9 days fluorescence remained low, while starting 
from day 10 post-inoculation a strong increase in fluorescence was noted (Fig. 6A). By this time-point 
the phosphate concentration in the medium was below 0.3 mmol.l–1. The expression of the plcABC genes 
thus seems to be induced by low phosphate concentration, although an impact of other potential stress 
factors linked to the consumption and limitation of essential nutriments may not be excluded. To fur-
ther investigate this point, an H37RvΔ PLC::plcA-egfp strain that also expressed DsRed under a consti-
tutive promoter was constructed. With the help of this strain promoter activity was studied at different 
phosphate ion concentrations, simultaneously controlling for the impact of cell density on fluorescence 
levels. Monitoring of green fluorescence relative to red fluorescence and absorbance levels showed that 
under low phosphate conditions green fluorescence increased strongly relative to the constant level of 
red fluorescence, confirming that the plcABC promoter was more strongly induced under low phosphate 
conditions (Fig. 6B). Finally, we also evaluated the GFP-fluorescence normalized to the cell density meas-
ured in OD, and again observed that at low phosphate concentration the promoter activity of the plcABC 
operon was increased (Fig.  6C). Starvation of phosphate ions thus seems to represent a stress that the 
bacteria try to counterbalance by induction of PLC production.
Finally, we also conducted experiments wherein the WT, Δ PLC and Δ PLC::plcABC H37Rv M. tuber-
culosis strains were grown in liquid medium supplemented with phosphatidylcholine as the sole phos-
phate source. As shown in Fig. 6D, the WT M. tuberculosis H37Rv strain and the complemented strain 
Figure 6. plcA-egfp fusion gene expression of M. tuberculosis H37RvΔPLC::Pr_plcA-egfp during growth 
in phosphate limiting conditions. (A) The curve shows the phosphate concentration in samples over time 
of in vitro growth. Histogram represents increase of the culture fluorescence intensity due to GFP expression 
over time. Results shown are representative of 2 independent experiments. Note that towards the end of the 
experiment the phosphate concentration slightly increased, which is plausibly due to lysis of some of the 
older bacterial cells. (B) Measurement of fluorescence divided into GFP and red fluorescence in a culture 
of H37RvΔ PLC::Pr_plcA-egfp complemented with a DsRed expressing plasmid. DS-red is expressed via a 
constitutive promoter while GFP expression is dependent on plcA promoter activity. (C) Promoter activity of 
M. tuberculosis H37RvΔ PLC::Pr_plcA-egfp in presence of decreasing phosphate concentration due to  
in vitro growth of culture during 7 days at 37 °C under shaking conditions. Measures show the ratio between 
fluorescence and absorbance, the first reflecting GFP expression levels and the latter reflecting cell density. 
(D) Survival of M. tuberculosis H37Rv WT and mutant strains in broth that provides phosphatidylcholine 
as the sole phosphate source. Results shown represent two different experiments. For each experiment the 
different strains tested were plated and counted in triplicate.
www.nature.com/scientificreports/
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survived better under these conditions compared to the Δ PLC mutant. It should be emphasized, how-
ever, that none of the strains was able to actively grow under these experimental settings.
Discussion
PLCs are widely distributed enzymes in living organisms. PLCs hydrolyze phospholipids such as phos-
phatidylcholine or sphingomyelin at the phosphodiester bond. In bacteria, these enzymes have been 
reported to function in a wide variety of cellular tasks during infection, including membrane lysis, intra-
cellular signalling, lipid metabolism and/or pathogenicity-associated activity40,41. In our study, we focused 
on the PLCs of M. tuberculosis, which belong to the superfamily of haemolytic phosphocholine-specific 
PLCs for which PLC of P. aeruginosa is the paradigm member42. Our initial objective was to eval-
uate whether these enzymes were involved in the process of phagosomal rupture induced by 
M. tuberculosis during infection of macrophages. In L. monocytogenes, or C. perfringens, PLCs play 
important roles together with pore forming listeriolysin or perfringolysin, respectively, to lyse the 
phagosomal membrane and allow the bacteria to gain access to the cytosol and promote cell-to-cell 
spread22,43. Concerning the infection with M. tuberculosis, the scenario seems more complex. While it 
was long thought that M. tuberculosis resists degradation in the phagosome by inhibiting the fusion 
with lysosomes, favoring intra-phagosomal survival and multiplication44, more recent studies by van 
der Wel and colleagues, using cryo-electron microscopy, provided evidence of cytosolic presence of 
M. tuberculosis at later stages of infection45. Similarly, cytosolic access of virulent M. tuberculosis strains 
was recently also reported by using a FRET-based read-out, combined with automated confocal micros-
copy24 or flow cytometry23. We here used the latter method to test the M. tuberculosis Δ PLC and WT 
strains for their ability to cause phagosomal rupture in comparison with a Δ ESX-1 (Δ RD1) negative 
control and found that the M. tuberculosis Δ PLC mutants and WT strains all showed very similar abil-
ities to gain cytosolic access.
Given the result that PLCs of M. tuberculosis were not required for inducing phagosomal rupture and 
cytosolic contact of M. tuberculosis, which are attributes usually linked to mycobacterial pathogenicity36, 
we subjected the Δ PLC mutants and WT strains to virulence analyses in in vitro/ex vivo and in vivo 
models. In the obtained data, we could only detect minor, not significant virulence differences between 
the Δ PLC and WT M. tuberculosis strains of two genetic backgrounds, i.e. MT103 and H37Rv, in the 3 
models used. These results, which were different from those of previous work reporting that PLCs were 
involved in virulence of M. tuberculosis15, remained puzzling.
Review of the available literature suggests that the number of functional PLC-encoding genes in dif-
ferent strains of the M. tuberculosis complex is highly variable and ranges from 0 to 4 copies. In many 
M. tuberculosis strains, including H37Rv, the plcD gene, which represents a hotspot for IS6110 insertion, 
is inactivated or deleted27,28,46. Similarly, extensive IS6110 insertion is also observed for the plcABC locus, 
but to a lesser extent47. Moreover, in a study on genetic polymorphisms affecting the four PLC encoding 
genes in M. tuberculosis isolates, Viana-Niero and coworkers found that 19 of 25 clinical isolates showed 
loss of parts of genes or complete genes from the plcABC and/or plcD loci, whereby five isolates retrieved 
from patients with active tuberculosis had all 4 plc genes interrupted48. PLC-encoding loci are also varia-
ble in different lineages of the M. tuberculosis complex; PlcA/B/C, which are also known as the “mtp40” 
mycobacterial protein(s), are missing from the M. bovis lineage due to the RD5 deletion, and also are 
absent from certain other tubercle bacilli27,49. In this respect it is also noteworthy that M. bovis strains 
with an IS6110 insertion in the remaining plcD gene were described. Interestingly, these strains without 
a functional PLC encoding gene were responsible for causing tuberculosis lesions in cattle for which 
no differences in the organ distribution relative to other M. bovis strains were noticed50. These findings 
are also in agreement with results from a high-density transposon screen, wherein PLC-encoding genes 
have not been identified as essential for in vivo growth of M. tuberculosis in the mouse model51. Taken 
together, these reports and our experimental findings with two different Δ PLC mutants of M. tuberculo-
sis cast doubt on an essential role of PLC in virulence of tubercle bacilli. PLCs of M. tuberculosis might 
play a less important role in the infectious lifecycle of M. tuberculosis than previously thought.
However, it is intriguing that despite the apparently marginal role of PLCs in virulence of M. tuberculosis, 
most strains have conserved one or more copies of PLC-encoding genes in their genomes, similar to cer-
tain non-tuberculous (NTM) mycobacteria. There are only few mycobacterial species that harbour genes 
encoding PLCs. Database analyses show that for the group of slow-growing mycobacteria, PLC-encoding 
genes are present in the genomes of smooth tubercle bacilli52, members of the M. tuberculosis com-
plex, members of the Mycobacterium kansasii-Mycobacterium gastri cluster, Mycobacterium asiaticum, 
and members of the Mycobacterium marinum-Mycobacterium ulcerans cluster. PLCs are absent from the 
genomes of Mycobacterium leprae, and members of the Mycobacterium avium-intercellulare complex. In 
the more distantly related rapid growing mycobacteria, only M. abscessus is known to carry a PLC, which 
shows 37% amino-acid identity with PLCs from M. tuberculosis and seems to be the result of a specific 
horizontal gene transfer (HGT) into M. abscessus13,53. In contrast, the PLCs in M. tuberculosis and other 
slow-growing mycobacteria seem to share a common origin with PLCs from different Gordonia species, 
with which they show about 60% amino acid identity. It seems thus likely that a common progenitor of 
the phylogenetic subgroup of slow-growing mycobacteria comprising M. kansasii, M. gastri, M. asiati-
cum, M. marinum and M. tuberculosis has acquired the PLC-encoding genes during evolution through 
HGT from more distantly related actinobacteria.
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This feature prompted us to search for potential alternative biological functions of PLCs in slow 
growing mycobacteria, not necessarily linked with virulence. As one hypothesis, PLCs of M. tuberculosis 
might help in the acquisition of phosphate. Cleavage of phospholipids by PLCs results in the generation 
of two molecular entities, a glycerol part and a residue containing a phosphate group, which might 
serve as a potential source of phosphate for the bacterium. The finding that expression of the plcA-egfp 
fusion was inversely correlated with the phosphate concentration in the medium suggests that the spe-
cific promoter activity might be downregulated under phosphate-sufficient environmental conditions. 
This assumption is in agreement with previous observations with PLCs from P. aeruginosa, for which an 
impact of phosphate concentration on plc gene regulation was noted20,39. Moreover, it has previously been 
reported that during infection of THP-1 cells by M. tuberculosis, the expression of the plcABC operon 
was upregulated for the first 24 h of infection15. Given the results obtained with our GFP-fusion assay, it 
is thus tempting to speculate that this upregulation might be related to a limited phosphate concentration 
inside the phagosome. Limitation of phosphate during phagosomal containment was also postulated 
by results from large-scale transcriptome studies, which found genes encoding phosphate transporters 
upregulated during infection18,54. It is plausible that M. tuberculosis can vary its supply in phosphate 
between inorganic phosphate, which is the preferred source of phosphorus for many bacteria18, and 
acquisition of organic phosphates through the action of phosphatases and/or phospolipases. A similar 
scenario was recently suggested for SpmT (Rv0888) of M. tuberculosis, which harbours a surface-exposed 
C-terminal sphingomyelinase domain and a putative N-terminal channel domain that mediates glucose 
and phosphocholine uptake across the outer membrane55. However, at present it remains unknown if 
the PLCs of M. tuberculosis may contribute to the phosphate supply of the bacterium in a similar way. 
Our results point to such a possibility, although more in depth studies are needed to clarify this question.
In conclusion, our study calls into question the impact of PLCs on virulence of M. tuberculosis, and 
provides new hints on putative alternative functions of PLCs in M. tuberculosis.
Methods
Bacterial strains and culture conditions. Escherichia coli DH10B and Top10 (Invitrogen) strains, 
used for cloning procedures, were grown on LB agar medium and/or LB broth. M. smegmatis mc2155 and 
M. tuberculosis strains were obtained from stock held at the Institut Pasteur. The M. tuberculosis MT103 
strain and the corresponding Myc2509Δ PLC mutant strain15 were a gift of Prof. Gicquel, Institut Pasteur.
Mycobacterial strains were cultured in Middlebrook 7H9 broth supplemented with ADC (Difco) and 
0.05% Tween 80 or on Middlebrook 7H11 medium supplemented with OADC (Difco). When required, 
antibiotics were included for selection purposes at following concentrations: Hygromycin (200 μ g.ml–1) 
and Zeocin (25 μ g.ml–1) for E. coli; Hygromycin (50 μ g.ml–1), Apramycin (50 μ g.ml–1), Kanamycin (25 μ g.
ml–1), Zeocin (25 μ g.ml–1), for mycobacteria.
For the PlcABC-promoter induction assay, phosphate-free Sauton medium was prepared as follows: 
L-asparagine 4 g/L, MgSO4-7 H2O 0.5 g/L; ammonium iron III citrate 0.05 g/L; citric acid 2 g/L; ZnSO4 
1% 0.1 ml/L; glycerol 60 ml/L. pH was adjusted between 7.2–7.3 by a buffer solution of ammonium 
hydroxide.
Construction of a plcABC deletion mutant in M. tuberculosis H37Rv. The M. tuberculosis H37Rv 
ΔplcABC mutant was constructed by allelic replacement using the recombineering method30. The allelic 
exchange substrate plcABC::Apra was obtained by a three step PCR approach56. Briefly, two 500–bp frag-
ments corresponding to the plcABC upstream and downstream regions were amplified by PCR from the 
M. tuberculosis H37Rv genomic DNA and linked to a third PCR fragment encoding the apramycin resist-
ance cassette, to generate the 2 kb-fragment plcABC::Apra. The plcABC::Apra fragment was thus used to 
transform a M. tuberculosis H37Rv recombinant strain containing the pJV53 vector. The pJV53 plasmid 
encodes the recombination proteins gp60 and gp6157, whose expression is induced by incubation with30 
0.2% acetamide for 24 h. The H37Rv-pJV53 acetamide-activated transformants were selected on solid 
medium for resistance to Kanamycin and Apramycin. The obtained Kanamycin and Apramycin resistant 
clones were thus tested for the plcABC deletion by PCR. One out of 116 tested clones revealed an ampli-
fication profile consistent with the replacement of the plcABC cluster with the apramycin cassette, and 
was thus subjected to Southern blot analyses. Genomic DNAs from M. tuberculosis strains were digested 
with AvrII, separated by gel electrophoresis and transferred onto Hybond-C-Extra nitrocellulose (GE). 
Hybridization was performed with [α -32 P] dCTP-labeled PCR-probe, specific for the plcABC down-
stream region, in 6x SSC, 0.5% SDS, 0.01 M EDTA, 5x Denhardt’s solution, 100 μg.ml−1 salmon-sperm 
DNA, at 68 °C. After washing, membranes were exposed to phosphorimager screens, which were scanned 
in a STORM phosphorimager31,57.
Construction of M. tuberculosis H37RvΔPLC complemented strains. Two different integrative 
pYUB412-based plasmids (pPlcABC and pYUB412-Pr_plcA-egfp) harbouring the plcABC operon and 
the plcA gene, respectively, were constructed. To obtain the pPlcABC plasmid, the plcABC operon and its 
natural promoter region, were amplified by PCR and cloned into the pYUB412 vector backbone. Similarly, 
to construct the pYUB412-Pr_plcA-egfp plasmid, the plcA gene and the plcABC promoter region were 
amplified by PCR using modified primers (Supplementary Table 1), which allow the introduction of 
additional HindIII and NheI recognition sequences in the amplified fragment obtained. The resulting 
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PCR product was digested and ligated into the HindIII-NheI-digested pYUB412::egfp (a pYUB412 deriv-
ative cosmid that allows the expression of transcriptional eGFP fusion protein constructs32).
Both pPlcABC and pYUB412-Pr_plcA-egfp constructs were used to transform the M. tuberculo-
sis H37RvΔ PLC mutant strain. Transformed clones were selected on solid medium for resistance to 
hygromycin.
PCR amplification and DNA Sequencing. PCR reactions to obtain fragments used in cloning 
procedures or in screening of transformed clones were carried out with Pwo (Roche) or similar high 
fidelity DNA polymerases, respectively, as previously reported58. Sequences of primers used in ampli-
fication reactions are listed in Table S1. All amplified PCR products and plasmids were sequenced by 
using the Big Dye cycle sequencing Kit (Applied Biosystems) in an automated DNA sequencer (Applied 
Biosystems, 3130xl genetic analyser).
Transformation of mycobacterial strains. To obtain mycobacterial competent cells, M. tuberculosis 
H37Rv and M. smegmatis Mc2155 were recovered from cultures at exponential growth, and washed three 
times in 10% glycerol. Aliquots (100 μ l) of freshly prepared electro-competent cells in glycerol 10% were 
transformed with 100 - 200 ng of vector DNA in 0.2-cm cuvettes (2.0 kV; 25 μ F : 1000 Ohms) at room 
temperature58. Transformant clones were selected by incubation on solid medium supplemented with the 
corresponding antibiotic for 2–3 weeks at 37 °C.
Phospholipase C assay. PLC activities were measured using the p-nitrophenylphosphorylcholine 
(p-NPPC) substrate (Sigma-Aldrich). Activity is defined as the ability of an enzyme to catalyse p-NPPC 
into p-nitrophenyl (p-NP) of yellow chromogenic nature. Briefly, 0.5 mg of total protein was incubated in 
3 ml of 10 mM Tris HCl (pH = 7.2), containing 5 mM of p-NPPC and 1.5% of sorbitol16. The reaction mix 
was incubated at 37 °C under shaking at 100 rpm. The reaction was stopped after 0, 1, 2, 3, 4, or 7 days 
by NaOH at 0.1 N (final concentration). The release of p-NP was measured at 410 nm. Buffer without 
proteins served as blank reference. For initial experimental setup, a control assay was performed with 
40 U of purified PLC from B. cereus (Invitrogen).
Phosphate assay by colorimetric method. Phosphate ions in presence of L(+ ) ascorbic acid 
(Merck) and ammonium molybdate tetra-hydrate (Sigma) form a complex showing a blue/green colour. 
Briefly, comparator samples containing between a standard range of 0 and 6.10−5 mol. L−1 of phosphate 
(KH2PO4) were prepared in 15 mL glass tubes. After adding 1 mL of stock solution of ascorbic acid at 
0.1 mol.L−1 and ammonium molybdate tetra-hydrate at 0.2 mol.L−1, the react volume was adjusted to 
10 ml final volume with Milli-Q (Millipore) purified water. All tubes were incubated at 80 °C in a water 
bath during 10 minutes and slowly cooled down to room temperature on the bench. Then all samples 
and comparator samples were diluted (d = 1/2) before measurement at 750 nm.
Infection of THP-1 derived macrophages with M. tuberculosis. THP-1 cells were grown at 37 °C 
with 5% CO2. Cells were maintained in RPMI 1640 + glutamax (Life technologies) and 10% of foetal 
bovine serum. THP-1 cells were seeded in 96 well plates at 7.5 × 104 cells per well, and differentiated by 
incubation with 10 ng.ml− 1 of PMA for 2 days. Before infection, the medium was removed and the wells 
were washed 3 times with PBS. Bacterial strains were added at a multiplicity of infection (MOI) = 1: 20 
(1 bacterium: 20 macrophages). After 2 hours (day 0) or 3, 5 and 7 days post-infection, cells were lysed 
in PBS 0,01% of Triton X-100. The number of viable intracellular mycobacteria was determined/counted 
by plating serial dilutions of macrophage lysates on solid medium.
Phagosomal rupture assay by flow cytometry analysis. Differentiated THP-1 cells were infected 
at MOI of 0.5 and were stained at day 3 post-infection with 8 μ M CCF-4 (Invitrogen) in EM buffer 
(120 mM NaCl, 7 mM KCl, 1.8 mM CaCl2, 0.8 mM MgCl2, 5 mM glucose and 25 mM Hepes, pH 7.3) 
complemented with 2.5 μ M probenecid, during 1 h at room temperature. Cells were then washed once 
in PBS and stained with anti-CD11b-APC (BD) monoclonal antibody in PBS containing 3% fetal calf 
serum and 0.1% NaN3 and fixed with 4% paraformaldehyde overnight at 4 °C. Cells were analyzed in a 
CyAn cytometer by use of Summit software (Beckman Coulter, France). Data were analyzed with FlowJo 
software (Treestar, OR).
M. tuberculosis virulence studies in mice. Six-week-old female CB17/Ico SCID mice (Charles 
River) were infected intravenously via the lateral tail vein with 200 μ l of bacterial suspension of 1 × 106 
CFU.ml−1. For aerosol infection, a customized apparatus was used following a previously established 
procedure59 Six-week-old female C57BL/6B mice (Charles-River) were infected with a suspension con-
taining 5 × 105 bacteria.ml−1 to obtain an inhaled dose of ca. 100 CFU. At selected time points after 
infection, mice were killed and organs homogenised using a tissue Lyser apparatus from Quiagen and 
2.5 mm diameter glass beads to determine CFU numbers as previously reported52,59.
All animal studies were approved by the Institut Pasteur Safety Committee (Protocol 11.245; exper-
imentation authorization number 75–1469), in accordance with European and French guidelines 
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(Directive 86/609/CEE and Decree 87–848 of 19 October 1987), and implicating approval from local 
ethical committees (CETEA 2013–0036).
plcABC-promoter induction assay. The H37RvΔ PLC::Pr_plcA-egfp strain was complemented with a 
DsRed expressing plasmid. The resulting strain was named H37RvΔ PLC::Pr_plcA-egfp::Pr-hsp60-DsRed. 
In this construct DsRed is expressed via a constitutive promoter while GFP expression is dependent on 
plcA promoter activity. Briefly, for these experiments bacteria were grown in 7H9 + ADC + Hygromycin 
50 μ g.ml−1/Zeocin 25 μ g.ml−1 medium until 0.4–0.6 OD. Bacteria of this preculture were inoculated in 
fresh Sauton medium containing 0.05% Tween80 and Hygromycin 50 μ g.ml−1/Zeocin 25 μ g.ml−1 at 0.05 
OD. After 7 days of culture, bacteria were harvested and centrifuged during 5 min at 5000 g. After 3 
washing steps, using 5 ml of fresh Sauton medium lacking PO43–, bacteria were inoculated at 0.05 final 
OD in Sauton medium containing phosphate or not. In addition, the bacterial quantities were mon-
itored by plating aliquots of each strain onto agar plates (in triplicate) for CFU determination. The 
GFP (Ex = 475 nm/Em = 504 nm) and DsRed fluorescence (Ex = 558/Em = 583) was monitored using a 
microplate reader (BGM Labtech) and analysed by Omega software. To avoid an increase of fluorescence 
due to the growth, we chose to normalize fluorescence values relative to absorbance. These ratio meas-
urements were converted in percentage, with the day 0, as reference point.
Mycobacterial phosphatidylcholine survival assay. M. tuberculosis H37Rv WT, ΔplcABC and 
complement strains were inoculated into phosphate-free Sauton medium supplemented with phosphati-
dylcholine (3.6 mM) (Sigma) as the sole phosphate source, considering that 1 mole of phosphate was 
equal to 1 mole of phosphatidylcholine. Addition of phosphatidylcholine rendered the medium turbid, 
which precluded the use of OD measurement. CFU counting was used as an alternative for quantification 
of bacteria, as previously reported60.
Statistical analyses. Potential statistical differences in bacterial loads were evaluated by ANOVA test 
with Tukey correction, after conversion of CFU numbers in Log10 CFU values. Statistical significance 
was considered to be a P value ≤ 0.05.
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